Search…

Duality Biotherapeutics-B (09606.HK) repurchased 141,200 shares for HK$14.6687 million on October 27.

27/10/2026

Zhitong Finance APP News, Duality Biotherapeutics-B (09606.HK) announced that on October 27, 2026, it spent HK$14.6687 million to repurchase 141,200 shares.

Latest

4 m ago

Huakai Yibai (300592.SZ) released its first three quarters performance, with net profit attributable to the parent company of 289 million yuan, a year-on-year increase of 484.45%.

5 m ago

Yoke Technology (002409.SZ) released its first three quarters results, with net profit attributable to shareholders of RMB 834 million, up 4.74% year on year.

6 m ago

Innovative New Materials (600361.SH) released its performance for the first three quarters, with net profit attributable to the parent company of 611 million yuan, a year-on-year decrease of 13.86%.

8 m ago

Ocumension Therapeutics-B (01477.HK): Fluocinolone acetonide intravitreal implant approved by the National Medical Products Administration for production in mainland China

9 m ago

Smart Control (002877.SZ) released its performance for the first three quarters, with net profit attributable to the parent company of 17.9768 million yuan, a year-on-year increase of 6.07%.

See all latest

+852 - 60190728

gmteight@futurecultural.com

Customer Support

Commercial Services